{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:34:24Z","timestamp":1792694064810,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10157-024-02482-x","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:01:51Z","timestamp":1710280911000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Frequency and prognosis of peritoneal dialysis-associated peritonitis in children"],"prefix":"10.1007","volume":"28","author":[{"given":"Misaki","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-6961","authenticated-orcid":false,"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Inoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"2482_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PK Li","year":"2022","unstructured":"Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42:110\u201353. https:\/\/doi.org\/10.1177\/08968608221080586.","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"2482_CR2","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1177\/089686080702702s46","volume":"27","author":"CC Szeto","year":"2007","unstructured":"Szeto CC, Chow KM. Gram-negative peritonitis \u2013 the Achilles heel of peritoneal dialysis? Perit Dial Int. 2007;27(Suppl 2):S267-271.","journal-title":"Perit Dial Int"},{"key":"2482_CR3","doi-asserted-by":"publisher","unstructured":"Brown MC, Simpson K, Kerssens JJ, Mactier RA, Scottish Renal Registry. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000\u20132007). Perit Dial Int. 2011;31:639\u201350. https:\/\/doi.org\/10.3747\/pdi.2010.00185.","DOI":"10.3747\/pdi.2010.00185."},{"key":"2482_CR4","doi-asserted-by":"publisher","unstructured":"Neu AM, Richardson T, De Souza HG, Mahon AR, Keswani M, Zaritsky J, Munshi R, Swartz S, Sethna CB, Somers MJG, Warady BA, SCOPE Collaborative Participants. Continued reduction in peritonitis rates in pediatric dialysis centers: results of the standardizing care to improve outcomes in pediatric end stage renal disease (SCOPE) Collaborative. Pediatr Nephrol. 2021;36:2383\u201391. https:\/\/doi.org\/10.1007\/s00467-021-04924-0.","DOI":"10.1007\/s00467-021-04924-0."},{"key":"2482_CR5","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00467-022-05450-3","volume":"37","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Zhou Q, Fang X, Shen X, Chen J, Zhang J, Miao Q, Guo W, Cao Q, Rao J, Shen Q, Xu H. Reduction in peritonitis rates: 18-year results from the most active pediatric peritoneal dialysis center in China. Pediatr Nephrol. 2021;37:2437\u201348. https:\/\/doi.org\/10.1007\/s00467-022-05450-3.","journal-title":"Pediatr Nephrol"},{"key":"2482_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00467-019-04248-0","volume":"34","author":"M Keswani","year":"2019","unstructured":"Keswani M, Redpath Mahon AC, Richardson T, Rodean J, Couloures O, Martin A, Blaszak RT, Warady BA, Neu A. Risk factors for early onset peritonitis: the SCOPE collaborative. Pediatr Nephrol. 2019;34:1387\u201394. https:\/\/doi.org\/10.1007\/s00467-019-04248-0.","journal-title":"Pediatr Nephrol"},{"key":"2482_CR7","doi-asserted-by":"publisher","unstructured":"Chadha V, Schaefer FS, Warady BA. Dialysis-associated peritonitis in children. Pediatr Nephrol. 2010;5:425\u201340. https:\/\/doi.org\/10.1007\/s00467-008-1113-6.","DOI":"10.1007\/s00467-008-1113-6."},{"key":"2482_CR8","doi-asserted-by":"publisher","unstructured":"Sethna CB, Bryant K, Munshi R, Warady BA, Richardson T, Lawlor J, Newland JG, Neu A. Risk factors for and outcomes of catheter-associated peritonitis in children: the SCOPE Collaborative. Clin J Am Soc Nephrol. 2016;11:1590\u20136. https:\/\/doi.org\/10.2215\/CJN.02540316.","DOI":"10.2215\/CJN.02540316."},{"key":"2482_CR9","doi-asserted-by":"publisher","unstructured":"Zaritsky JJ, Hanevold C, Quigley R, Richardson T, Wong C, Ehrlich J, Lawlor J, Rodean J, Neu A, Warady BA, SCOPE Investigators. Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative. Pediatr Nephrol. 2017;33:713\u201322. https:\/\/doi.org\/10.1007\/s00467-017-3839-5.","DOI":"10.1007\/s00467-017-3839-5."},{"key":"2482_CR10","doi-asserted-by":"publisher","unstructured":"Chan EYH, Borzych-Duzalka D, Alparslan C, Harvey E, Munarriz RL, Runowski D, Vidal E, Coccia PA, Jankauskiene A, Principi I, Serdaroglu E, Szczepanska M, Tse Y, Vazquez A, Weaver DJ, Schaefer F, Warady BA; International Pediatric Peritoneal Dialysis Network. Colostomy in children on chronic peritoneal dialysis. Pediatr Nephrol. 2020;35:119\u201326. https:\/\/doi.org\/10.1007\/s00467-019-04372-x.","DOI":"10.1007\/s00467-019-04372-x."},{"key":"2482_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.nephro.2015.06.005","volume":"11","author":"M Jellouli","year":"2015","unstructured":"Jellouli M, Ferjani M, Abidi K, Hammi Y, Boutiba I, Naija O, Zarrouk C, Ben Abdallah T, Gargah T. Peritonitis in pediatric patients receiving peritoneal dialysis. Nephrol Ther. 2015;11:558\u201363. https:\/\/doi.org\/10.1016\/j.nephro.2015.06.005.","journal-title":"Nephrol Ther"},{"key":"2482_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00467-017-3872-4","volume":"33","author":"R Munshi","year":"2018","unstructured":"Munshi R, Sethna CB, Richardson T, Rodean J, Al-Akash S, Gupta S, Neu AM, Warady BA. Fungal peritonitis in the standardizing care to improve outcomes in pediatric end stage renal disease (SCOPE) Collaborative. Pediatr Nephrol. 2018;33:873\u201380. https:\/\/doi.org\/10.1007\/s00467-017-3872-4.","journal-title":"Pediatr Nephrol"},{"key":"2482_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12882-020-02014-1","volume":"21","author":"M Alsuhaibani","year":"2020","unstructured":"Alsuhaibani M, Aldosari E, Rahim KA, Alzabli S, Alshahrani D. Fungal peritonitis in children on peritoneal dialysis at a tertiary care centre. BMC Nephrol. 2020;21:400. https:\/\/doi.org\/10.1186\/s12882-020-02014-1.","journal-title":"BMC Nephrol"},{"key":"2482_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000484344","volume":"45","author":"D Ponce","year":"2018","unstructured":"Ponce D, de Moraes TP, Pecoits-Filho R, Figueiredo AE, Barretti P. Peritonitis in children on chronic peritoneal dialysis: the experience of a large national pediatric cohort. Blood Purif. 2018;45:118\u201325. https:\/\/doi.org\/10.1159\/000484344.","journal-title":"Blood Purif"},{"key":"2482_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpam.2020.09.001","volume":"8","author":"SM AlZabli","year":"2021","unstructured":"AlZabli SM, Alsuhaibani MA, BinThunian MA, Alshahrani DA, Al Anazi A, Varghese S, Rose V, Rahim K. Peritonitis in children on peritoneal dialysis: 12 years of tertiary center experience. Int J Pediatr Adolesc Med. 2021;8:229\u201335. https:\/\/doi.org\/10.1016\/j.ijpam.2020.09.001.","journal-title":"Int J Pediatr Adolesc Med"},{"key":"2482_CR16","doi-asserted-by":"publisher","unstructured":"Hoshii S, Wada N, Honda M, Japanese Study Group of Pediatric Peritoneal Dialysis. A survey of peritonitis and exit-site and\/or tunnel infections in Japanese children on PD. Pediatr Nephrol. 2006;21:828\u201334. https:\/\/doi.org\/10.1007\/s00467-006-0004-y.","DOI":"10.1007\/s00467-006-0004-y."},{"key":"2482_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12887-020-1936-2","volume":"20","author":"K Al Mokali","year":"2020","unstructured":"Al Mokali K, Al Sannaa Z, Al Mutairi F, Ahmed AE. Factors influencing occurrence of peritonitis in Saudi children on peritoneal dialysis. BMC Pediatr. 2020;20:42. https:\/\/doi.org\/10.1186\/s12887-020-1936-2.","journal-title":"BMC Pediatr"},{"key":"2482_CR18","doi-asserted-by":"publisher","unstructured":"Kempf C, Holle J, Berns S, Henning S, Bufler P, M\u00fcller D. Feasibility of percutaneous endoscopic gastrostomy insertion in children receiving peritoneal dialysis. Perit Dial Int. 2022;42:482\u20138. https:\/\/doi.org\/10.1177\/08968608211057651.","DOI":"10.1177\/08968608211057651."},{"key":"2482_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196499","volume":"13","author":"W Lu","year":"2018","unstructured":"Lu W, Kwan BC, Chow KM, Pang WF, Leung CB, Li PK, Szeto CC. Peritoneal dialysis-related peritonitis caused by Pseudomonas species: insight from a post-millennial case series. PLoS ONE. 2018;13: e0196499. https:\/\/doi.org\/10.1371\/journal.pone.0196499.","journal-title":"PLoS ONE"},{"key":"2482_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2215\/CJN.00010109","volume":"4","author":"B Siva","year":"2009","unstructured":"Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol. 2009;4:957\u201364. https:\/\/doi.org\/10.2215\/CJN.00010109.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2482_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0966-842x(00)01913-2","volume":"9","author":"TF Mah","year":"2001","unstructured":"Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34\u20139. https:\/\/doi.org\/10.1016\/s0966-842x(00)01913-2.","journal-title":"Trends Microbiol"},{"issue":"6","key":"2482_CR22","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1046\/j.1523-1755.2001.00748.x","volume":"59","author":"CC Szeto","year":"2001","unstructured":"Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, Lui SF, Li PK, et al. Clinical course of peritonitisdue to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. Kidney Int. 2001;59(6):2309\u201315. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00748.x.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-024-02482-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-024-02482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:03:22Z","timestamp":1718874202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-024-02482-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2482"],"URL":"https:\/\/doi.org\/10.1007\/s10157-024-02482-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Koichi Kamei has received research funding from the Public Foundation of Vaccination Research Center, and the Taiju Life Social Welfare Foundation; donations from Chugai Pharmaceutical Co. Ltd., Teijin Pharma Ltd., Kyowa Kirin Co. Ltd., Shionogi & Co. Ltd., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co. Ltd, and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Terumo Co. Ltd., Baxter Ltd., and Zenyaku Kogyo Co., Ltd. Shuichi Ito has received research funding from Zenyaku Kogyo Co., Ltd., and Teijin Pharma Ltd.; and honoraria from Astrazeneca PLC and Alexion Pharmaceuticals Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Ethics Committee of the National Center for Child Health and Development (Approval no. 2022\u2013169).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}